Skip to main content
Funded Studies

Jean-Christophe Rochet, PhD

Professor at Purdue University

Location: West Lafayette, IN United States

Jean-Christophe (Chris) Rochet obtained his PhD degree in the Department of Biochemistry at the University of Alberta (Edmonton, Canada) in 1998. From 1999-2002, Dr. Rochet worked as a post-doctoral fellow with Dr. Peter Lansbury in the Department of Neurology at Harvard Medical School. His postdoctoral research (supported by a fellowship from the Human Frontier Science Program Organization) focused on the role of alpha-synuclein self-assembly in Parkinson's disease.

In the fall of 2002, Dr. Rochet joined the Department of Medicinal Chemistry and Molecular Pharmacology at Purdue University, where he is now a professor. The overall goals of his research program are to understand mechanisms of neurotoxicity and neuroprotection in PD by characterizing PD-related gene products (e.g., alpha-synuclein, DJ-1), and to use this information to develop new therapeutic strategies.

Dr. Rochet's honors include a Melvin Yahr Fellowship from the International Federation of Parkinson's Disease and a PhRMA Foundation Sabbatical Fellowship in Pharmacology and Toxicology.


Associated Grants

  • Effects of Post-translational Modifications on Alpha-synuclein Aggregation

    2018


  • Neuroprotective Effects of NFE2L1 in Parkinson's Models

    2018


  • Neuroprotective Effects of Endosulfine-alpha in Parkinson's Disease

    2017


  • Neuroprotective Effects of Endosulfine-alpha in PD

    2016


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.